Please login to the form below

Not currently logged in
Email:
Password:

Quintiles, HKPI and Ramco form Egyptian JV

New company, HKPI-JV, will provide specialised contract sales force and sales promotion outsourcing services to Egyptian biopharma companies

Quintiles has formed a joint venture with Health Kare Pharma International (HKPI) and Ramco Import and Export to provide specialised pharmaceutical contract sales force and sales promotion outsourcing services in Egypt.

HKPI is an Egyptian firm offering sales and marketing support for major local manufacturers, and Ramco is the agent/importer in Egypt for several multinational pharmaceutical companies and an affiliate company of Global Napi Pharmaceuticals.

Known as HKPI-JV, with principal offices in Cairo, the new company will assist bio-pharmaceutical companies commercialise therapies in Egypt by recruiting, training and placing pharmaceutical sales representatives; forming and managing outsourced sales and medical marketing teams; product marketing; and sales forecasting.

HKPI-JV will begin operations during the fourth quarter of 2010.

Commenting on the joint venture, Rich Pilnik, executive vice president of Quintiles and president of global commercial solutions stated: "We have allied with these biopharma companies to expand our commercial service offerings into a new market that is an attractive point of entry into the region."

"The biopharma market in Egypt has tremendous growth potential and biopharma customers in the region now have a resource that brings the best of both local and global expertise to the table," Pilnik said.

30th September 2010

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?...
Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...